Asebio Values positively the anticipate of fiscal credits for R&D

The president of the Spanish Association of Bioempresas (Asebio), Regina Revilla, moved to the secretary of State of Inland revenue, Miguel Ferré, his satisfaction for the patronal for having entered in the Law of support to the emprendedores and his internationalisation the anticipate of the fiscal credits generated by the deductions associated to the cost in R&D for companies that still do not have positive quotas in the tax of societies. The president of Asebio participated in the day Law of support to the emprendedores and his internationalisation: mercantile novelties, fiscal and labour, organised the past 8 November by Garrigues in collaboration with Asebio.

This law also collects in his articulated a measure of support and attraction of the foreign investor to the country. In this point, Asebio treated to promote a drafted more ambitious, with conditions especially beneficial for investors in companies of high technology and of recent creation, although finally it did not collect in the articulated. Nevertheless, Revilla explained that “the direct impact of these measures is difficult to estimate a priori but does not fit doubt that to effects of reputation and mark, are launching a message to the world that is timely and suitable. We can not forget that the behaviour investor that historically has incentivado in Spain by the road of the deductions, above any another, has been the purchase of houses. Therefore it is well that our taxation was coherent with the model of country to which want to advance, and in this, think that this Law can consider pioneering.”

Inauguration of the day.

The secretary of State of Inland revenue Miguel Ferré, argued that the best measure for the biotechnology is that the internal demand grow. Besides, it explained that monetizar the fiscal advances to the R&D is more public cost, but has done in plough to achieve a greater collaboration and commitment of the public sector and of the private, and added that it results more useful that the direct subvention. “This measure is a commitment of the Government in the sense of renunciation to income to achieve that it keep the level of cost in the R&D”, explained Ferré. Besides, also it did allusion to the grave problem that supposes the morosidad, so much public like private in Spain. Thus, it underlined that they have approved the financial conditions for the third plan of payment to providers by 13.000 million euros and that the Law of Commercial Debt goes to generate transparency with regard to the indexes of morosidad.

In this day, also was present the general secretary of Science, Technology and Innovation, Marisa Poncela. Poncela Announced that it is working to publish this year the Royal decree that develop bonuses to the cotizaciones of the Social hygiene and on the other hand, announced that it is setting up a stamp of innovative company so that those companies that obtain it have a public recognition in diverse normative. The president of Garrigues, Antonio Garrigues, praised the fast path of the sector biotecnológico business in the country and explained that the public sector no longer can play the tractor trucks paper that came developing up to now in investment in R&D, by what the private enterprise has to begin to project more.

As it explained during the celebrated day in the headquarters of Garrigues the responsible partner of the pharmaceutical sector and biotecnológico of the Mercantile department of Garrigues, José Fernández-Rañada, the Law brings cause of the grave crisis suffered by our country, that justifies the need to carry out a structural reform of the business surroundings. In this line, the norm has by object support to the emprendedor and the business activity, favour his development, growth and internationalisation and boost the culture emprendedora and some favourable surroundings to the economic activity, so much in the initial moments when beginning the activity, as in his back development, growth and internationalisation.